Brian Raisler, Ph.D. - Publications

Affiliations: 
University of Florida, Gainesville, Gainesville, FL, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature. 460: 225-30. PMID 19525930 DOI: 10.1038/nature08151  0.399
2008 Raisler BJ, Nozaki M, Baffi J, Hauswirth WW, Ambati J. Toward a higher fidelity model of AMD. Advances in Experimental Medicine and Biology. 613: 185-92. PMID 18188944 DOI: 10.1007/978-0-387-74904-4_21  0.471
2006 Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, ... ... Raisler BJ, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 443: 993-7. PMID 17051153 DOI: 10.1038/Nature05249  0.323
2006 Lutty GA, Chan-Ling T, Phelps DL, Adamis AP, Berns KI, Chan CK, Cole CH, D'Amore PA, Das A, Deng WT, Dobson V, Flynn JT, Friedlander M, Fulton A, Good WV, ... ... Raisler BJ, et al. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Molecular Vision. 12: 532-80. PMID 16735995  0.579
2004 Hauswirth WW, Li Q, Raisler B, Timmers AM, Berns KI, Flannery JG, LaVail MM, Lewin AS. Range of retinal diseases potentially treatable by AAV-vectored gene therapy. Novartis Foundation Symposium. 255: 179-88; discussion 1. PMID 14750604 DOI: 10.1002/0470092645.Ch14  0.584
2002 Raisler BJ, Berns KI, Grant MB, Beliaev D, Hauswirth WW. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proceedings of the National Academy of Sciences of the United States of America. 99: 8909-14. PMID 12072560 DOI: 10.1073/Pnas.122247299  0.629
2002 Mori K, Gehlbach P, Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Investigative Ophthalmology & Visual Science. 43: 1994-2000. PMID 12037010  0.577
Show low-probability matches.